News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
745,988 Results
Type
Article (48785)
Company Profile (375)
Press Release (696817)
Multimedia
Podcasts (128)
Webinars (18)
Section
Business (209388)
Career Advice (2055)
Deals (36197)
Drug Delivery (126)
Drug Development (84653)
Employer Resources (176)
FDA (16993)
Job Trends (15271)
News (355440)
Policy (33640)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2740)
Academic (1)
Accelerated approval (34)
Adcomms (33)
Allergies (142)
Alliances (51240)
ALS (177)
Alzheimer's disease (1739)
Antibody-drug conjugate (ADC) (337)
Approvals (17203)
Artificial intelligence (538)
Autoimmune disease (161)
Automation (38)
Bankruptcy (367)
Best Places to Work (11914)
BIOSECURE Act (23)
Biosimilars (194)
Biotechnology (254)
Bladder cancer (164)
Brain cancer (63)
Breast cancer (665)
Cancer (4993)
Cardiovascular disease (430)
Career advice (1735)
Career pathing (35)
CAR-T (309)
CDC (48)
Celiac Disease (2)
Cell therapy (828)
Cervical cancer (37)
Clinical research (71961)
Collaboration (1796)
Company closure (4)
Compensation (1183)
Complete response letters (68)
COVID-19 (2819)
CRISPR (97)
C-suite (863)
Cystic fibrosis (153)
Data (6297)
Decentralized trials (2)
Denatured (32)
Depression (142)
Diabetes (518)
Diagnostics (6854)
Digital health (45)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (258)
Drug pricing (201)
Drug shortages (31)
Duchenne muscular dystrophy (243)
Earnings (91260)
Editorial (61)
Employer branding (21)
Employer resources (154)
Events (121046)
Executive appointments (990)
FDA (20138)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (24)
Funding (1520)
Gene editing (213)
Generative AI (45)
Gene therapy (677)
GLP-1 (1052)
Government (4803)
Grass and pollen (7)
Guidances (383)
Healthcare (19447)
HIV (60)
Huntington's disease (49)
IgA nephropathy (82)
Immunology and inflammation (271)
Immuno-oncology (60)
Indications (105)
Infectious disease (3084)
Inflammatory bowel disease (198)
Inflation Reduction Act (14)
Influenza (110)
Intellectual property (247)
Interviews (321)
IPO (16933)
IRA (51)
Job creations (3721)
Job search strategy (1451)
JPM (66)
Kidney cancer (16)
Labor market (83)
Layoffs (592)
Leadership (32)
Legal (8098)
Liver cancer (98)
Longevity (15)
Lung cancer (671)
Lymphoma (382)
Machine learning (44)
Management (59)
Manufacturing (812)
MASH (173)
Medical device (14019)
Medtech (14073)
Mergers & acquisitions (20340)
Metabolic disorders (1348)
Multiple sclerosis (163)
NASH (18)
Neurodegenerative disease (344)
Neuropsychiatric disorders (95)
Neuroscience (3027)
Neurotech (1)
NextGen: Class of 2026 (6765)
Non-profit (4653)
Now hiring (65)
Obesity (645)
Opinion (283)
Ovarian cancer (166)
Pain (213)
Pancreatic cancer (231)
Parkinson's disease (297)
Partnered (34)
Patents (499)
Patient recruitment (494)
Peanut (57)
People (60228)
Pharmaceutical (78)
Pharmacy benefit managers (29)
Phase 1 (22489)
Phase 2 (31594)
Phase 3 (23606)
Pipeline (5216)
Policy (302)
Postmarket research (2741)
Preclinical (9610)
Press Release (69)
Prostate cancer (248)
Psychedelics (56)
Radiopharmaceuticals (297)
Rare diseases (918)
Real estate (6094)
Recruiting (71)
Regulatory (25263)
Reports (51)
Research institute (2557)
Resumes & cover letters (357)
Rett syndrome (28)
RNA editing (20)
RSV (78)
Schizophrenia (152)
Series A (254)
Series B (197)
Service/supplier (13)
Sickle cell disease (103)
Special edition (26)
Spinal muscular atrophy (174)
Sponsored (42)
Startups (3776)
State (2)
Stomach cancer (20)
Supply chain (104)
Tariffs (89)
The Weekly (94)
Vaccines (1037)
Venture capital (91)
Weight loss (430)
Women's health (89)
Worklife (19)
Date
Today (97)
Last 7 days (589)
Last 30 days (2119)
Last 365 days (30997)
2026 (3031)
2025 (31346)
2024 (36417)
2023 (41176)
2022 (52468)
2021 (57012)
2020 (55286)
2019 (47816)
2018 (36113)
2017 (33253)
2016 (32746)
2015 (38711)
2014 (32428)
2013 (27610)
2012 (29730)
2011 (30388)
2010 (28572)
Location
Africa (787)
Alabama (83)
Alaska (7)
Arizona (312)
Arkansas (13)
Asia (41041)
Australia (6825)
California (11391)
Canada (3286)
China (1155)
Colorado (483)
Connecticut (487)
Delaware (336)
Europe (90861)
Florida (1702)
Georgia (365)
Hawaii (3)
Idaho (62)
Illinois (874)
India (65)
Indiana (523)
Iowa (23)
Japan (430)
Kansas (129)
Kentucky (40)
Louisiana (26)
Maine (72)
Maryland (1399)
Massachusetts (8309)
Michigan (320)
Minnesota (630)
Mississippi (5)
Missouri (137)
Montana (32)
Nebraska (28)
Nevada (121)
New Hampshire (83)
New Jersey (3026)
New Mexico (32)
New York (3028)
North Carolina (1529)
North Dakota (10)
Northern California (5526)
Ohio (336)
Oklahoma (22)
Oregon (42)
Pennsylvania (2300)
Puerto Rico (22)
Rhode Island (47)
South America (1153)
South Carolina (66)
South Dakota (1)
Southern California (4416)
Tennessee (175)
Texas (1768)
United States (40667)
Utah (338)
Vermont (1)
Virginia (260)
Washington D.C. (84)
Washington State (948)
West Virginia (4)
Wisconsin (114)
Wyoming (2)
745,988 Results for "genetic therapy inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Genethon Advances Groundbreaking Gene Therapies for Patients with Rare Genetic Diseases
January 27, 2026
·
1 min read
Press Releases
Opus Genetics Launches Gene Therapy Clinical Trial for MERTK-related Retinitis Pigmentosa
January 27, 2026
·
6 min read
Press Releases
PacBio Announces Plans for Collaboration With n-Lorem Foundation and EspeRare to Advance Precision Therapies for Rare Genetic Diseases
January 13, 2026
·
8 min read
China
AstraZeneca Pledges $15B More in Chinese Investments for Cell Therapies, Radiopharma
AstraZeneca has risen as one of pharma’s most prolific investors in China, including a $630 million pledge last week for full rights to AbelZeta’s cell therapy for cancer.
January 29, 2026
·
1 min read
·
Tristan Manalac
Cell Therapy
6 Companies Hanging On in Cell Therapy
As big pharmas including Takeda and Novo Nordisk flee the cell therapy space and smaller biotechs shutter their operations, these players are sticking around to take the modality as far as it can go.
December 1, 2025
·
9 min read
·
Tristan Manalac
Rare diseases
FDA Unwraps ‘Plausible Mechanism Pathway’ for Personalized Therapies
The plausible mechanism pathway “could accelerate gene therapy/editing development,” analysts at William Blair said Thursday, while adding that additional clarity is needed.
November 13, 2025
·
3 min read
·
Tristan Manalac
Press Releases
Geneticure Inc. Granted New U.S. Patent for Genetic Test to Predict Response in Renal Denervation for Hypertension
July 11, 2025
·
2 min read
Press Releases
Alps Group Inc Announces Potential Pipeline Expansion Beyond CELESOME(+) Following Publication of Nebulized Human Umbilical Cord Mesenchymal Stem Cell Exosome Therapy
February 1, 2026
·
4 min read
Press Releases
Opus Genetics to Participate in Upcoming Medical and Industry Conferences in February 2026
February 2, 2026
·
2 min read
Press Releases
Opus Genetics Featured on Good Morning America Spotlighting Breakthrough Gene Therapy Restoring Sight in Patients with Inherited Blindness
November 4, 2025
·
4 min read
1 of 74,599
Next
